Todd Herrington, MD
Neurology · Boston, MANPI 1417184904
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.2% of it on its own, with 1 other manufacturer making up the rest. Among neurology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $729.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$44K
- Boston Scientific$17K
Across 68 payments — averaging $7735.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$507K
- Boston Scientific$18K
- Bayer$2K
What the payments were for
- Consulting fees$11,90919%
- Speaking & faculty fees$15,12025%
- Travel & lodging$31,64852%
- Food & beverage$2,6074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 73 | $44,233 |
| Boston Scientific | 11 | $17,052 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PERCEPT PC BRAINSENSE$21,704
- GENERAL - THERAPIES$14,064
- ACTIVA$5,711
- Percept$4,320
- SPECTRA WAVEWRITER$2,400
- ACTIVA PC$405
- GENERAL DBS$129
How this compares
$61,284 in reported general payments places this provider in the 90th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 111 | $246,457 |
| NuplazidPimavanserin Tartrate | 19 | $118,941 |
| GocovriAmantadine Hcl | 20 | $78,870 |
| NourianzIstradefylline | 22 | $41,152 |
| Entacapone | 49 | $13,292 |
| Pramipexole ErPramipexole Di-Hcl | 18 | $12,078 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 320 | $11,740 |
| Rasagiline Mesylate | 39 | $8,305 |
| RivastigmineRivastigmine Tartrate | 103 | $7,615 |
| AmantadineAmantadine Hcl | 74 | $4,461 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 115 | $4,450 |
| Carbidopa | 19 | $2,651 |
| Gabapentin | 36 | $1,274 |
| Modafinil | 12 | $1,267 |
| Duloxetine Hcl | 26 | $1,122 |
Paid to pharmacies, not to this prescriber.
Other neurology in Boston
- Christopher WrightBoston$2.5M
- Thomas ScammellBoston$617K
- Alfred SandrockBoston$490K
- Pushpa NarayanaswamiBoston$420K
- Roy FreemanBoston$390K
- Michael LevyBoston$387K
- Leeann BurtonBoston$325K
- Ilena GeorgeBoston$316K
- Andrew BudsonBoston$304K
- Denis BalabanBoston$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.